Transjugular intrahepatic portosystemic shunts: An update
- 1 March 2003
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 9 (3), 207-217
- https://doi.org/10.1053/jlts.2003.50045
Abstract
Transjugular intrahepatic portosystemic shunts (TIPS) have been used in the treatment of complications of portal hypertension. TIPS is used for the control of acute variceal bleeding and for the prevention of vericeal rebleeding when pharmacologic therapy and endoscopic therapy have failed. Patients with refractory ascites with adequate hepatic reserve and renal function who fail to respond to large volume paracentesis may be reasonable candidates for TIPS. Promising indications for TIPS are Budd-Chiari syndrome uncontrolled by medical therapy, severe portal hypertensive gastropathy, refractory hepatic hydrothorax, and hepatorenal syndrome. TIPS cannot be recommended for preoperative portal decompression solely to facilitate liver transplantation. Special care should be taken to insure proper placement of the stent to avoid increasing the technical difficulty of the transplantation procedure. The major limiting factors for TIPS success are shunt dysfunction and hepatic encephalopathy. Because shunt stenosis is the most important cause of recurrent complications of portal hypertension, a surveillance program to monitor shunt patency is mandatory. The MELD score may be useful in predicting post-TIPS survival, and also in counseling patients and their families.Keywords
This publication has 59 references indexed in Scilit:
- Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized studyHepatology, 2002
- Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosisJournal of Hepatology, 2001
- A model to predict survival in patients with end-stage liver diseaseHepatology, 2001
- The Role of Transjugular Portosystemic Shunting in Patients with AscitesNew England Journal of Medicine, 2000
- A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with AscitesNew England Journal of Medicine, 2000
- Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Clinical, laboratory, psychometric, and electroencephalographic investigationsHepatology, 1998
- Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systemsHepatology, 1998
- Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansionHepatology, 1998
- Transvenous intrahepatic portosystemic shuntsGastroenterology, 1996
- Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trialJournal of Hepatology, 1996